Amniotic Fluid Optical Density Determination as a Test for Assessment of Fetal Lung Maturity.
1 other identifier
interventional
200
1 country
1
Brief Summary
To determine the relationship between the result of amniotic fluid optical density between 26 and 36 6/7 weeks of pregnancy and the risk of developing neonatal respiratory distress syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started May 2014
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 4, 2015
CompletedFirst Posted
Study publicly available on registry
January 6, 2015
CompletedJanuary 6, 2015
January 1, 2015
6 months
January 4, 2015
January 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Respiratory Distress Syndrome, Newborn
Diagnosis of Respiratory Distress Syndrome in the neonatal period. The diagnosis was made by the neonatologist in charge (using clinical and radiological parameters).
1 month
Study Arms (1)
Preterm fetus
OTHERPatients with pregnancies between 26 and 36 6/7 weeks of pregnancy. Before the birth, a sample of amniotic fluid was taken and analyzed using optical density at 650nm. A value above 0.15 was considered an indication of fetal lung maturity.
Interventions
A sample of amniotic fluid was taken before the birth of fetus between 26 and 36 6/7 weeks of pregnancy.
Eligibility Criteria
You may qualify if:
- Pregnancy between 26 and 36 6/7 weeks.
You may not qualify if:
- Problems in the handling of the amniotic fluid sample that prevented the calculation of the optical density.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saint Thomas Maternity Hospital
Panama City, Panama
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Osvaldo Reyes, MD
Saint Thomas Hospital, Panama
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Coordinator of Research
Study Record Dates
First Submitted
January 4, 2015
First Posted
January 6, 2015
Study Start
May 1, 2014
Primary Completion
November 1, 2014
Study Completion
December 1, 2014
Last Updated
January 6, 2015
Record last verified: 2015-01